Skip to content

Clinical trials

Hyperlipidemias trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Country / region: Czechia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20053
20061
20111
20121
20136
20141
20212
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Amgen4
Novartis Pharmaceuticals3
Takeda3
Solvay Pharmaceuticals2
89bio, Inc.1
AstraZeneca1
Genentech, Inc.1
Ionis Pharmaceuticals, Inc.1
NewAmsterdam Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias22
Hypercholesterolemia9
Dyslipidemias6
Cardiovascular Diseases4
Myocardial Infarction3
Stroke3
Diabetes Mellitus, Type 22
Hyperlipoproteinemia Type II2
Hypertriglyceridemia2
Metabolic Diseases2

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.